A #DNA-based #vaccine candidate for #COVID_19 worked by using engineered bacteriophage can be delivered through a #nasal_spray.
Production of the #virus_like_particle (VLP) is the first step in developing a #vaccine for #COVID_19, which will now undergo preclinical testing for safety and efficacy by Medicago.
Multi-drug nanoparticles containing #adenosine and #squalene, encapsulated in a type of #vitamin_E can help humans fight off the severe #cytokine_storm that occurs in severe cases of #COVID_19.
Oxford #nanopore MinION device is the only portable and real-time device that allows for DNA and RNA #sequencing analysis of the samples collected from all patients with positive #COVID_19 tests.
The 2nd generation development of the #COVID_19 rapid antibody IgM/IgG test has seen the introduction of #gold_nanoparticles into the testing strip.
#Nanomedicine research about the role of #chloroquine in #nanoparticle uptake in cells showed promise in developing an effective treatment for #COVID_19.
A consortium of international partners are working to develop a functional prototype for an antigen detecting, rapid-response, #lateral_flow test for #COVID_19.
The rapid #COVID_19 test based on IgG-IgM combined #antibody and #gold_nanoparticles has great potential benefit for the fast screening of COVID-19 infections within 15 minutes.
New #COVID_19 vaccine candidate has been developed using proprietary #recombinant_protein nanoparticle technology platform to generate antigens derived from the #coronavirus spike (S) protein.